Perrigo Company plc (BVMF:P1RG34)

Market Cap	10.23B -48.3%
Revenue (ttm)	22.87B -2.5%
Net Income	-276.73M
EPS	-2.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	5.50
Dividend	4.67 (6.10%)
Ex-Dividend Date	Nov 27, 2025

Volume	51
Average Volume	23
Open	74.95
Previous Close	74.95
Day's Range	74.95 - 76.50
52-Week Range	66.36 - 147.95
Beta	0.40
RSI	44.69
Earnings Date	Feb 27, 2026

About Perrigo Company

Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain rel...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1887
• Employees: 8,379
• Stock Exchange: Brazil Stock Exchange
• Ticker Symbol: P1RG34

Financial Performance

In 2024, Perrigo Company's revenue was $4.37 billion, a decrease of -6.06% compared to the previous year's $4.66 billion. Losses were -$171.80 million, 1252.8% more than in 2023.

Financial numbers in USD